Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended
Oct. 31, 2014
Oct. 31, 2013
Expenses:    
Research and development $ 2,501,268 $ 773,958
General and administrative 1,558,938 1,214,535
Loss from operations (4,060,206) (1,988,493)
Other income (expense):    
Non-cash interest expense   (12,293)
Net loss before income taxes (4,060,206) (2,000,786)
Provision (benefit) for income taxes 910 50,700
Net loss, net of tax $ (4,061,116) $ (2,051,486)
Basic and diluted net loss per common share (in dollars per share) $ (0.02) $ (0.01)
Weighted average shares used in computing basic and diluted net loss per common share (in shares) 244,631,076 144,247,064